DNMT3A Cooperates with YAP/TAZ to Drive Gallbladder Cancer Metastasis
Advanced Science · 2024
DOI: 10.1002/advs.202308531 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2024. Verfasst von Sunwang Xu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biliary-Pancreatic Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200125, China. Hauptthemen laut MEDLINE: DNA Methyltransferase 3A, Gallbladder Neoplasms. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, The First Affiliated Hospital of Fujian Medical University.
Abstract (Originalsprache)
Gallbladder cancer (GBC) is an extremely lethal malignancy with aggressive behaviors, including liver or distant metastasis; however, the underlying mechanisms driving the metastasis of GBC remain poorly understood. In this study, it is found that DNA methyltransferase DNMT3A is highly expressed in GBC tumor tissues compared to matched adjacent normal tissues. Clinicopathological analysis shows that DNMT3A is positively correlated with liver metastasis and poor overall survival outcomes in patients with GBC. Functional analysis confirms that DNMT3A promotes the metastasis of GBC cells in a manner dependent on its DNA methyltransferase activity. Mechanistically, DNMT3A interacts with and is recruited by YAP/TAZ to recognize and access the CpG island within the CDH1 promoter and generates hypermethylation of the CDH1 promoter, which leads to transcriptional silencing of CDH1 and accelerated epithelial‐to‐mesenchymal transition. Using tissue microarrays, the association between the expression of DNMT3A, YAP/TAZ, and CDH1 is confirmed, which affects the metastatic ability of GBC. These results reveal a novel mechanism through which DNMT3A recruitment by YAP/TAZ guides DNA methylation to drive GBC metastasis and provide insights into the treatment of GBC metastasis by targeting the functional connection between DNMT3A and YAP/TAZ.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biliary-Pancreatic Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200125, China.
- Department of Thyroid and Breast Surgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou, 350005, China.
- Central Laboratory, Fujian Medical University Union Hospital, Fuzhou, 350001, China.
ORCID-Profile: Tao Chen
Förderung
- National Natural Science Foundation of China
- The First Affiliated Hospital of Fujian Medical University
Zitieren
APA
Xu, S., Yuan, Z., Jiang, C., Chen, W., Li, Q., & Chen, T. (2024). DNMT3A Cooperates with YAP/TAZ to Drive Gallbladder Cancer Metastasis. Advanced Science. https://doi.org/10.1002/advs.202308531
Vancouver
Xu S, Yuan Z, Jiang C, Chen W, Li Q, Chen T. DNMT3A Cooperates with YAP/TAZ to Drive Gallbladder Cancer Metastasis. Advanced Science. 2024. doi:10.1002/advs.202308531
BibTeX
@article{Xu2024,
author = {Xu, Sunwang and Yuan, Zhiqing and Jiang, Cen and Chen, Wei and Li, Qiwei and Chen, Tao},
title = {DNMT3A Cooperates with YAP/TAZ to Drive Gallbladder Cancer Metastasis},
journal = {Advanced Science},
year = {2024},
doi = {10.1002/advs.202308531}
}
EUVIMED